[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"symptom\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:symptom":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,41,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100641843","symptom-severity-posture-pain-and-physical-activity-in-gastroesophageal-reflux-disease-100641843",false,"NCT07643779","Symptom Severity, Posture, Pain, and Physical Activity in Gastroesophageal Reflux Disease","Investigation of Symptom Severity, Posture, Musculoskeletal Pain, and Physical Activity Levels in Patients With Gastroesophageal Reflux Disease","Inclusion Criteria:\n\n* Being diagnosed with gastroesophageal reflux disease (GERD)\n* Age between 18 and 65 years\n* Willingness to participate in the study assessments\n\nExclusion Criteria:\n\n* Presence of a diagnosed psychiatric disorder\n* Pregnancy or breastfeeding status","ALL","18 Years","65 Years",{"count":20,"type":21},51,"ESTIMATED","OBSERVATIONAL","This study is a cross-sectional research designed to investigate symptom severity, posture, musculoskeletal pain, and physical activity levels in individuals with gastroesophageal reflux disease (GERD).",[25,26,27,28],"Gastroesophageal Reflux Disease (GERD)","Symptom","Musculoskeletal Pain","Physical Activity","NOT_YET_RECRUITING","2026-06-11",{"date":32,"type":33},"2026-06-15","ACTUAL",{"date":35,"type":21},"2026-07-01",{"date":37,"type":21},"2026-12-30",{"name":39,"class":40},"Karabuk University","OTHER",{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":72},"100640554","mindfulness-meditation-in-hemodialysis-patients-100640554","NCT07620990","Mindfulness Meditation in Hemodialysis Patients","The Effect of Mindfulness Meditation on Sleep, Stress, and Symptoms in Hemodialysis Patients: A Randomized Controlled Trial","MIND-HD","Inclusion Criteria:\n\n* Patients aged between 18 and 75 years\n* Patients receiving hemodialysis treatment for at least 3 months\n* Patients with cognitive functions suitable for the intervention (dementia score ≥21)\n* Patient without hearing, vision or communication problems\n* Patients without a psychiatric diagnosis\n* Patients able to use a smartphone or tablet\n* Patients not participating in another study\n* Patients not using sleep medication or antipsychotic drugs\n\nExclusion Criteria:\n\n* Patients younger than 18 years or older than 75 years\n* Patients receiving hemodialysis treatment for less than 3 months\n* Patients with cognitive impairment unsuitable for the intervention (dementia score ≤21)\n* Patient with hearing, vision or communication disabilities\n* Patients diagnosed with psychiatric disorders\n* Patients unable to use a smartphone or tablet\n* Patients participating in another study\n* Patients using sleep medication or antipsychotic drugs","75 Years",{"count":51,"type":21},50,"INTERVENTIONAL",[54],"NA","This randomised controlled study aims to evaluate the effects of mindfulness meditation on sleep quality, perceived stress and symptoms levels ion hemodialysis patients. Participants in the intervention group will receive a 4 week mindfulness meditation program in addition to routine care. Outcomes will be assessed before and after the intervention using validated measurement tools.",[57,58,59,26],"Hemodialysis","Stress","Sleep Quality",[61,57,59,58,26],"Mindfulness Meditation","RECRUITING","2026-06-01",{"date":65,"type":33},"2026-06-02",{"date":67,"type":33},"2026-04-15",{"date":69,"type":21},"2026-08",{"name":71,"class":40},"Cyprus Aydin University",4,{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":81,"targetDuration":4,"studyType":52,"phases":83,"briefSummary":84,"conditions":85,"keywords":89,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":97,"leadSponsor":99,"locationsCount":101},"100632831","advanced-symptom-palliation-through-integrated-relief-engagement-100632831","NCT07518797","Advanced Symptom Palliation Through Integrated Relief Engagement","Palliative Oncology Symptoms Management Utilizing Beacon© Platform's Analysis of Aggregated Patient-Provided Data - Feasibility Prospective Study","ASPIRE AI","Inclusion Criteria:\n\n* Outpatients treated and followed at the Davidoff Center\n* Stage III-IV cancer\n* Eastern Cooperative Oncology Group (ECOG) 0-3\n* Age: 18 and older\n* Have not been engaged with the ambulatory palliative service over the last three months\n* Speaks and reads a language supported by the study protocol (e.g., Hebrew, Arabic, English)\n* Able to wear a smartwatch\u002Fsensor for prolonged periods and independently operate the app\n* Actively symptomatic patients requiring palliative care (not long-term stable survivors)\n* Enrolled in another clinical study if the existing study allows\n\nExclusion Criteria:\n\n* Patient without active disease\n* Patients are actively engaged with the ambulatory palliative service in the - Davidoff Center or elsewhere\n* Patient with chronic stable symptoms (\\>6 months) related to their cancer or treatment\n* ECOG \\> 3\n* Does not speak and read languages supported by the study protocol (e.g., Hebrew, Arabic, English)\n* Legal incompetence\n* Does not or cannot use a smartphone, or is unable to fill out questionnaires\u002Frecord messages, or is unable to wear a smartwatch\u002Fsensor, or operate the app independently",{"count":82,"type":21},40,[54],"Beacon is a digital platform that processes objective and subjective aggregated data provided by patients. Objective data is provided by standard wearables, while subjective data is provided by patient-reported outcome measures (PROMs), comprising written and vocal patient reporting.\n\nThe ASPIRE.AI study is a prospective study evaluating the feasibility of clinicians' use of aggregated data that was provided by patients and analyzed through \"Beacon\", and its influence on advanced cancer patients' palliative symptoms management.\n\nApproximately 40 consecutive eligible ambulatory advanced cancer patients first attending the palliative unit in the Davidoff Center will be enrolled. The trial will continue for \\~1 year, with each patient participating in this trial for a total of about 12 weeks.\n\nAll participants will receive the intervention. The intervention comprises the palliative standard of care treatment along with the usage of the Beacon digital platform, which enables comprehensive data collection and aggregation regarding the patient's biopsychosocial status, and thus, the patient's symptom burden.\n\nData collected and aggregated through Beacon includes Beacon data provided by the patients via wearables (smartwatch\u002Fsensors), smartphones, and written and recorded PROMs.\n\nResearchers will then evaluate physician engagement with the platform, Influence on treatment, and the physician user experience rating as well as patients' adherence, satisfaction with Beacon usage, and changes in patients' symptom burden and quality of life.",[86,26,87,88],"Cancer","Quality of Life","AI (Artificial Intelligence)",[90,91,92],"Palliative care","Biopsychosocial","Physician engagement","2026-04-02",{"date":95,"type":33},"2026-04-09",{"date":63,"type":21},{"date":98,"type":21},"2027-07-01",{"name":100,"class":40},"Tzeela Cohen",1]